ANYONE FOLLOWING OUR METHODOLGY SHOULD HAVE EXITED CANCER , DIABETES AND AEROSPACE STOCKS

Under: AEROSPACE, CANCER, DIABETES No Comment
www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of ...
Read more »

TIGHTEN STOPS ON CANCER STOCKS

Under: CANCER, EXEL, OSIP, PARD, SNTA No Comment
We have profits on both our long and short cancer trades. Our analysis indicates that it is time to either take profits and exit the positions or make stops extremely tight so that profits ...
Read more »

CONSIDER LIGHTLY ADDING TO CANCER STOCK SHORTS ON THIS RALLY

Under: CANCER, EXEL, OSIP, PARDR, SNTA 1 Comment
www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of ...
Read more »

STATUS OF CANCER STOCKS

Under: CANCER, EXEL, OSIP, PARDR, SNTA No Comment
Per our earlier post, we are short on OSIP from $32.2, SNTA from $3.50and EXEL from $5.35.We are long on PARD from $4.45www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO ...
Read more »
Follow

Get every new post delivered to your Inbox

Join other followers